Crossref
A novel marker for prediabetic conditions: Uric acid-to-HDL cholesterol ratio
Bratislava Medical Journal · 2024 · 125 (03) · 145-148
DOI: 10.4149/bll_2023_130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bratislava Medical Journal, 2024. Verfasst von Sumeyye Buse Balci und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Prediabetic State. Die Arbeit wurde bisher 29-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Prediabetic StateHumansCholesterol, HDLUric AcidRetrospective StudiesBlood Glucose
Substanzen
Cholesterol, HDLUric AcidBlood Glucose
Zitieren
APA
Balci, S. B., Atak, B. M., Duman, T., Ozkul, F. N., & Aktas, G. (2024). A novel marker for prediabetic conditions: Uric acid-to-HDL cholesterol ratio. Bratislava Medical Journal, 125(03), 145-148. https://doi.org/10.4149/bll_2023_130
Vancouver
Balci SB, Atak BM, Duman T, Ozkul FN, Aktas G. A novel marker for prediabetic conditions: Uric acid-to-HDL cholesterol ratio. Bratislava Medical Journal. 2024;125(03):145-148. doi:10.4149/bll_2023_130
BibTeX
@article{Balci2024,
author = {Balci, Sumeyye Buse and Atak, Burcin Meryem and Duman, Tuba and Ozkul, Feyza Nihal and Aktas, Gulali},
title = {A novel marker for prediabetic conditions: Uric acid-to-HDL cholesterol ratio},
journal = {Bratislava Medical Journal},
year = {2024},
volume = {125},
number = {03},
pages = {145--148},
doi = {10.4149/bll_2023_130}
}
EUVIMED